According to MarketsandMarkets™, the Body Fluid Analysis Market is projected to grow from about USD 2.62 billion in 2026 to ...
By Sahil Pandey June 24 (Reuters) - ALZpath said on Wednesday it had signed a global licensing agreement with Abbott ...
Plus Therapeutics to become Cerenome, to trade under new Nasdaq ticker CNSY on August 3, 2026Affirms 2026 guidance on key milestones Reports ...
The CNSide® CSF Assay Platform supports rapid diagnoses, treatment monitoring, and treatment guidance for patients with leptomeningeal metastases. The superior clinical utility of CNSide® over ...
(Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy ® (sacituzumab govitecan-hziy), a first-in-class Trop-2-directed antibody-drug conjugate (ADC), ...
New research linking heart rate variability to glymphatic clearance could lead to a simple new biomarker of dementia risk.
There has been growing recognition that gut health may play a role in Parkinson’s disease—a brain disorder. This article ...
The updated guidelines expand sequencing recommendations to include CSF-based molecular profiling for patients with inoperable high-grade gliomas and glioblastomas when a tissue biopsy is not feasible ...
A newly discovered brain peptide, AETA, may hold the key to detecting Alzheimer’s long before memory loss becomes visible.
A single ICD-10 code, a missing modifier or a misclassified procedure intent can shift a colonoscopy from a fully covered preventive service to a medically necessary diagnostic one, which could change ...
WASHINGTON — A North Carolina man pleaded guilty Wednesday to defrauding Medicare out of $60 million through a kickback ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results